AEON Biopharma, Inc.
AEON
$0.7002
$0.01021.48%
AMEX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 145.18% | 570.47% | -99.75% | -96.68% | 32.23% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 215.94% | 99.47% | 48.21% | 149.86% | 877.97% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 155.34% | 393.23% | -74.45% | -85.98% | 50.98% |
|
|||||
Total Current Assets | 155.34% | 393.23% | -74.45% | -85.98% | 50.98% |
Net Property, Plant & Equipment | -18.68% | 186.93% | 156.40% | 136.23% | 120.68% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -14.71% |
Total Assets | 103.38% | 355.11% | -54.10% | -77.27% | 65.72% |
|
|||||
Total Accounts Payable | 28.94% | -62.64% | 74.44% | 15.38% | -52.25% |
Total Accrued Expenses | -31.45% | -3.58% | -13.48% | -39.52% | -15.14% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 80.60% | -3.90% | -56.47% | -56.76% | -99.82% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -12.47% | -45.85% | 8.43% | -24.34% | -88.19% |
|
|||||
Total Current Liabilities | -12.47% | -45.85% | 8.43% | -24.34% | -88.19% |
Long-Term Debt | 14.16% | 161.84% | -- | -- | -78.19% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -19.18% | -- | -- | 2,215.38% | 870.77% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -74.81% | -98.85% | -96.78% | -93.18% | -- |
Total Liabilities | -18.31% | -87.53% | -80.17% | -75.28% | -77.46% |
|
|||||
Common Stock & APIC | 3.44% | 4.56% | 5.71% | 5.77% | 95.48% |
Retained Earnings | -0.38% | 28.59% | 8.87% | 3.06% | 15.82% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 43.28% | 94.29% | 81.33% | 75.01% | 90.79% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 43.28% | 94.29% | 81.33% | 75.01% | 90.79% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 43.28% | 94.29% | 81.33% | 75.01% | 80.85% |
|